Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1060.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 24.7 | n/a |
Pr/Book | 2.3 |
Latest | F'cast | |
---|---|---|
Revenue | 810.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 1.06 | (20.38) | (54.48)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 0.69 | (1.85) | (1.19)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 0.05 | (5.63) | 5.50p | 3.2 | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 0.06 | (5.98) | (5.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 0.50 | (7.75) | (4.70)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Grant of Options | 20-Dec-2024 | 12:16 | RNS |
Director/PDMR Shareholding | 20-Dec-2024 | 12:12 | RNS |
Posting of annual report and notice of AGM | 05-Dec-2024 | 15:00 | RNS |
Genedrive full-year revenue rises | 29-Nov-2024 | ShareCast |
Director dealings: Genedrive chairman snaps up s... | 15-Aug-2024 | ShareCast |
Genedrive makes first commercial sales of CYP2C1... | 12-Aug-2024 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
20-Dec-24 | Buy | Russell Shaw | 2.19p | 1,000,000 | £21,890.00 |
20-Dec-24 | Buy | Gino Miele | 2.20p | 1,135,208 | £24,974.58 |
20-Dec-24 | Buy | Ian David Gilham | 2.34p | 225,000 | £5,274.00 |
Currency | UK Pounds |
Share Price | 2.28p |
Change Today | -0.23p |
% Change | -9.00 % |
52 Week High | 8.13 |
52 Week Low | 1.45 |
Volume | 1,301,938 |
Shares Issued | 543.14m |
Market Cap | £12.36m |
Beta | 1.03 |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:03 | 12,701 @ 2.30p |
11:57 | 100,000 @ 2.28p |
11:56 | 500,000 @ 2.27p |
11:54 | 22,763 @ 2.28p |
11:42 | 10,696 @ 2.30p |
You are here: research